Le Lézard
Classified in: Health
Subjects: LAW, AVO

Hazelden Betty Ford Foundation files federal lawsuit--the latest in the nonprofit's push for addiction treatment industry reform


CENTER CITY, Minn., Aug. 21, 2018 /PRNewswire/ -- The Hazelden Betty Ford Foundation has filed a federal lawsuit against two companies and an individual who own websites that the nonprofit addiction treatment leader says infringe on its trademarks and contain deceptive, misleading content harmful to consumers.

The nation's largest nonprofit treatment organization. (PRNewsFoto/Hazelden Betty Ford Foundation)

"At the Hazelden Betty Ford Foundation, our mission, first and foremost, is to make sure people affected by substance use disorders get the care they need," said Mark Mishek, president and CEO of the Hazelden Betty Ford Foundation. "Unfortunately, vulnerable people and families suffering from substance use disorders are being harmed by the unethical, and sometimes illegal, marketing and business practices of some who work in the addiction treatment industry."

The lawsuit, filed Aug. 14 in U.S. District Court in Minneapolis, is part of a larger effort by the Hazelden Betty Ford Foundation and other well-regarded addiction treatment providers to reform their own industry. Growing market demand for addiction treatment, driven by the opioid crisis and expanded insurance coverage, has attracted unprecedented private investment and a rapid influx of new providers motivated by profit over people, Mishek recently told a U.S. House committee investigating deceptive sales and marketing practices in the field. 

"Our organization is collaborating with policymakers to pursue industry reforms and more robust professional standards to protect consumers. This legal action is another way we are fighting against unscrupulous practices in our field and advocating for people who need help," Mishek said.

The lawsuit points to specific examples of how the defendants' websites used the name "Hazelden Betty Ford Foundation" and other trademarks alongside phone numbers that do not connect callers to the Hazelden Betty Ford Foundation. The lawsuit seeks an injunction that would bar the defendants from using the Hazelden Betty Ford Foundation name and trademarks and from continuing other forms of unlawful conduct.

"We have initiated this legal action to protect our reputation and to ensure that people seeking help for life-threatening substance use disorders get that help from providers they know and trust, rather than from individuals and companies trying to profit from their addiction through deception," said Jennifer Lohse, vice president and general counsel for the Hazelden Betty Ford Foundation. "As a leader in the addiction treatment industry, we sometimes see our name and brand used by others without our permission in ways that we think are illegal and harmful to consumers. People with substance use disorders should be able to count on honesty and transparency from those working in the addiction treatment field."

The full 30-page complaint can be read online here.

About the Hazelden Betty Ford Foundation
The Hazelden Betty Ford Foundation is a force of healing and hope for individuals, families and communities affected by addiction to alcohol and other drugs. It is the nation's largest nonprofit treatment provider, with a legacy that began in 1949 and includes the 1982 founding of the Betty Ford Center. With 17 sites in California, Minnesota, Oregon, Illinois, New York, Florida, Massachusetts, Colorado and Texas, the Foundation offers prevention and recovery solutions nationwide and across the entire continuum of care to help youth and adults reclaim their lives from the disease of addiction. It includes the largest recovery publishing house in the country, a fully accredited graduate school of addiction studies, an addiction research center, an education arm for medical professionals and a unique children's program, and is the nation's leader in advocacy and policy for treatment and recovery. Learn more at HazeldenBettyFord.org and on Twitter @hazldnbettyford.

 

SOURCE Hazelden Betty Ford Foundation


These press releases may also interest you

at 16:05
BeiGene, Ltd. , a global oncology company, today announced it will share research outcomes from its broad hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31 - June 4, 2024....

at 16:05
Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from Cidara Therapeutics. This provides Mundipharma with global ownership of rezafungin including ongoing development and distribution. Rezafungin...

at 16:05
Arrowhead Pharmaceuticals, Inc. today announced that it will host a webcast and conference call on May 9, 2024, at 4:30 p.m. ET to discuss its financial results for the fiscal second quarter ended March 31, 2024. Webcast and Conference Call and...

at 16:05
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced three accepted abstracts at the 2024 American Society of...

at 16:03
First Quarter 2024 Total Revenues of $649 Million (+9% Y/Y and +13% at Constant Currency Y/Y); GAAP Diluted Earnings per Share (EPS) of $0.46 (+70% Y/Y) and Non-GAAP Diluted Earnings per Share of $0.71 (+18% Y/Y) VOXZOGO® Net Product Revenues of $153...

at 16:01
Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that several abstracts detailing new selinexor data have been selected for presentation at the 2024 American Society of...



News published on and distributed by: